Biotech Leader Bio-Rad to Evaluate SAGA Diagnostics’ Technology

Biotech Leader Bio-Rad to Evaluate SAGA Diagnostics’ Technology

LUND, Sweden — /June 14, 2017/ — SAGA Diagnostics AB, a genomic testing company focused on precision oncology and non-invasive monitoring of circulating tumor DNA in cancer patients, today announces an agreement with a global provider of life science and clinical diagnostic products, Bio‑Rad Laboratories, Inc. (NYSE: BIO and BIOb), who will evaluate one of […]